Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Tumor Talk: Is It Really Harmless If It’s Called a Tumor?

Continue reading
06 2 月

UltraSensitiveTM SP Immunohistochemical Staining Procedure

Continue reading
06 2 月

If faith has a color, it must be Chinese red!

Continue reading
06 2 月

Expression of Keratin in Normal Tissues, Cells, and Tumors

Continue reading
06 2 月

Heroes Return, Welcome Home!

Continue reading
06 2 月

Third-party Independent Laboratory Collaborates with Maixin on p16/Ki-67 Dual Staining Detection to Comprehensively Tap into the Billion-Dollar Cervical Cancer Screening Market

Continue reading
06 2 月

A Chronicle of the Maxin Team’s Visit to MD Anderson Cancer Center

Continue reading
06 2 月

Dou MaxVisionTM Immunohistochemistry Double Staining Procedure

Continue reading
06 2 月

Mr. Mahajan, Consul General of the Thai Consulate General in Xiamen, and three other delegates visited our company.

Continue reading
06 2 月

2017 Sino-US Pediatric Oncology Pathology Summit — New Advances in Pediatric Pathology

Continue reading
  • «
  • ‹
  • 36
  • 37
  • 38
  • 39
  • 40
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar